Summary
Cytochrome P-450dbl gene (CYP2D6) Xba I genotypes were investigated in 43 unrelated healthy Japanese and 51 patients with idiopathic Parkinson’s disease (IPD), using genomic DNA hybridization analysis with a cDNA probe encoding cytochrome P- 450dbl. Restriction fragment length polymorphisms (RFLPs) were observed in both populations, but the frequencies of alleles detected by restriction enzyme Xba I differed significantly. The relative risk of IPD is 2.15 times greater for idividuals with a Xba I 44 kb allele compared to those without the allele (x2 = 4.149, d.f. = 1, p < 0.05). Furthermore, the relative risk of IPD is 6.32 times greater for the Xba I 44 kb homozygotes than the Xba I 29 kb homozygotes (x2 = 4.935, d.f. = 1, p < 0.05). These data suggest that the Xba I 44 kb allele of CYP2D6 is one of the genetic factors making humans susceptible to IPD acquisition.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Barbeau A, Cloutier T, Roy M, Plasse L, Paris S, Poirier J (1985) Ecogenetics of Parkinson’s disease: 4-hydroxylation of debrisoquine. Lancet ii: 1213–1215
Barbeau A, Roy M, Cloutier T, Plasse L, Paris S (1986) Environmental and genetic factors in the etiology of Parkinson’s disease. Adv Neurol 45: 299–306
Fonne-Pfister R, Meyer UA (1988) Xenobiotic and endobiotic inhibitors of cytochrome P-450dbl function, the target of the debrisoquine/sparteine type polymorphism. Biochem Pharmacol 37: 3829–3835
Gonzalez FJ, Skoda RC, Kimura S, Umeno M, Zanger UM, Nebert DW, Gelboin HV, Hardwick JP, Meyer UA (1988) Characterization of the common genetic defect in humans deficient in debrisoquine metabolism. Nature 331: 442–446
Heim M, Meyer UA (1990) Genotyping of poor metabolisers of debrisoquine by allelespecific PCR amplification. Lancet 336: 529–532
Ishizaki T, Eichelbaum M, Horai Y, Hashimoto K, Chiba K, Dengler HJ (1987) Evidence for polymorphic oxidation of sparteine in Japanese subjects. Br J Clin Pharmacol 23: 482–485
Kunkel LM, Smith KD, Bother SH, Borgaonkar DS, Wachtel SS, Miller OJ, Breg WR, Jones HW, Rary JM (1977) Analysis of human Y-chromosome-specific reiterated DNA in chromosome variants. Proc Natl Acad Sci USA 74: 1245–1249
Langston JW, Ballard P, Tetrud JW, Irwin I (1983) Chronic parkinsonism in humans due to a product of meperidine-analogy synthesis. Science 219: 979–980
Mahgoub A, Idle JR, Dring LG, Lancaster R, Smith RL (1977) Polymorphic hydroxylation of debrisoquine in man. Lancet ii: 584–586
Nakamura K, Goto F, Ray WA, McAllester CB, Jacqz E, Wilkinson GR, Branch RA (1985) Interethnic differences in genetic polymorphism of debrisoquine and mephnytoin hydroxylation between Japanese and Caucasian populations. Clin Pharmacol Ther 38: 402–408
Niznik HB, Tyndale RF, Sallee FR, Gonzalez FJ, Hardwick JP, Inaba T, Kalow W (1990) The dopanime transporter and cytochrome P450IID1 (debrisoquine 4-hydroxylase) in brain; resolution and identification of two distinct [3H]-GBR- 12935 binding proteins. Arch Biochem Biophys 276: 424–432
Shahi GS, Moochhala SM, Das NP (1989) Depression of the hepatic cytochrome P450 monooxygenase system by the neurotoxin l-methyl-4-phenyl-l,2,3,6- tetrahydropyridine (MPTP). Pharmacol Toxicol 64: 107–110
Skoda RC, Gonzalez FJ, Demierre A, Meyer UA (1988) Two mutant alleles of the human cytochrome P-450dbl gene (P450C2D1) associated with genetically deficient metabolism of debrisoquine and other drugs. Proc Natl Acad Sci USA 85: 5240–5243
Southern EM (1975) Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol 98: 503–517
Yue QY, Bertilsson L, Dahl-Puustinen ML, Sawe J, Sjogvist F, Johansson I, Ingelman- Sundberg M (1989) Dissassociation between debrisoquine hydroxylation phenotype and genotype among Chinese. Lancet ii: 870
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 Springer-Verlag/Wien
About this paper
Cite this paper
Kondo, I., Kanazawa, I. (1991). Association of Xba I allele (Xba I 44kb) of the human cytochrome P-450dbI (CYP2D6) gene in Japanese patients with idiopathic Parkinson’s disease. In: Nagatsu, T., Narabayashi, H., Yoshida, M. (eds) Parkinson’s Disease. From Clinical Aspects to Molecular Basis. Key Topics in Brain Research. Springer, Vienna. https://doi.org/10.1007/978-3-7091-9146-0_11
Download citation
DOI: https://doi.org/10.1007/978-3-7091-9146-0_11
Publisher Name: Springer, Vienna
Print ISBN: 978-3-211-82272-2
Online ISBN: 978-3-7091-9146-0
eBook Packages: Springer Book Archive